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10:30 
~Tha Mechanism of  In Endothel ial  Improvement 
Function by Pravastatln: Direct Effect or Through 
Cholesterol  Lowering 
R,A, Vogel, M,C, Correttt, G,D, Plotnick, University of Marylnnd School ot 
M~ll(~lne, ~sltlmom, M~lryland, LISA 
B~ckgrogn¢ Cflnlcol trials of cholesterol owering using HMG.CoA reduotasa 
Inhlblto~ have demonstrated vow early mdu~tlons tn oardlovasoutar events 
raising the question of whether these agent~ directly affect vascular biology, 
possibly tndopecdont of their ~hotostorol lowering propodlos, 
Ml~thod~" To determine whether on HMG,CoA reductsso Inhibitor, proves. 
tails, improves endothelial function Independent el Its effect on ohotostoml, 
we maaeumd flow. mediated brachiat adeW vasodllatlon using hlgh.roaolu. 
tton ultrasound bolero and slier 1 day, 1, ~, 4, ¢'md t2 weeks of administration 
of pravnststln 20 mgld~y in 7 healthy, normocholestarolemlo, middle.sUed 
loon, 
R~glt~: Total and LOL.gholosteml tell altar P. weeks el provastatin sdmin. 
tsttatlon from 198 I 15 and 131 ~ 15 mgldL respectively, to 162 ~ ~2 and 
96 :t 13 mgldl (p - 0,01), No nddtkonal reductions in cholesterol worn ob. 
sowed altar 12 weeks of treatment, Flew.mediated vasodllatton, measured 
as peroont dlamotor change, increased significantly only after 2 weeks of 
treatment', baseline 7 ~ 3%, 1 day 7 ± 3%, 1 week 10 :t 3%, 2 weeks 13 t. 
3% (p ~ 0,01), 4 weeks 12 ~ 2% (p ~. 0.01), nnd 12 weeks f4 ~ 5% (p ~. 
001) 
Conclusions: Those data confirm that (~holostorot lowering by the HMG- 
CoA roducfsse inhibitor pravastatln rapidly improves endothelial function, 
but tlndll that no vascular blologlcat affect is ohsn~ed before significant 
cholesterol owering occum. These data sttggost hat pravastatln improves 
endothellol function through a cholesterol-lowering rather than a direct effect. 
10:45 
F'~-6- '~ Short-term Aggreaelve LDL-Lowerlng, 
Endothelial-mediated Arterloiar Vesodl iatst lon and 
Capillary Permeabil ity In Patients With 
Atheresclerotlc Vascular Disease 
G Dell'grog ~ , S Bandlnelli ~, G Ponno ~, R Navatesi 2, R Podrtnolli ~ 'I 
Clinics Medea, Italy: Oiabetologia, Universita' di Piss, Italy 
E~ckground: Although consistent evidence shows an improvement of ederi- 
olar endothelial function after aggmsslvo LDL cholesterol (LDLc~o~)-Ioworing, 
less croat is how early this change takes place, In addition, it te unknown the 
effect ot lowering cholesterol on the function of the ondothelium located at 
the capLIlan/bed whom most of the endothollat coils am contained. 
Material & Methods: (MEANS ¢ SD): High.dose (40 rag/die) stmvastatin 
iS) was administered for one month in fourteon non diabetic (glucose: 99 
:, 14 mojdl. HbAtc: 5,7 ± 0.4%), normotenslve (ASPM..,t,,: 124:1:11/74 ± 
7 mmHg) males (age: 58 ,~: 5 yrs) with athemsclemtic peripheral vascular 
disease and LDl..c.o~ ~ 130 mg/dl (166 ~: 38 mg/dl). Evaluation variables 
were I. Forearm vasodilatation [% forearm blood Ilow (FeF, ml/min/dl, venous 
ptethysmography) cha=lges Imm baseline] to ietrearterial acetylcheline (ACH, 
7.5, 15, 30 s~g/min x 5 minutes each), an endothelial-mediated vasodilator, 2. 
Transcapillary albumin escape rote (TERse, °,Jhr, the one-hour decline rate 
of i.v. ~;sl-albumin), a measure of macmmolecular permeability of capillary 
ondothotium, 3. Maximum fomam'~ vasoditatation (peak FBF after 13.minute 
ischomia) to account for non specific vasodilator mechanisms. 
Results: (Means ± SD): S reduced LDL cho~ by 39% (to 101 ~: 32 mg/dl, 
p .. 0,0001) without significant changes in the response to ACH (+180 ~ 24, 
27'3 ± ?0, 419 ± 67% vs 230 ± 57%, 309 ± 86, 461 ~. 65%); on the contrary, 
TER,~It, decreased tram 10.4 ± 1.9 to 8.7 ± 2.9 (p -~ 0.05). Postischemic FBF 
(59.3 ± 13 vs 58.7 ± 13 ml/min/dl) was stable. 
Conclusions: Improvement of arteriolar endothelial function is still incon- 
sistent after one-month S therapy, in spite of drastic LDl..c~,o~ reduction. The 
statistically significant reduction in TER .~ by S over the same treatment 
period indicates the influence el LDI.<,o= on systemic capillary permeability, 
and suggests that changes in capillary and arteriolar function may follow 
rather different ime-ceurses, 
11:00 
~'~ Acute Choleaterol  Leukocyte Reduction Decreases 
Adhesiveness end Improves Peripheral 
Microcireulatory Function in Patients With Familial 
Hypercholesterolemla 
1", Sampintto, C. Palombo, G, Blgalll, M. Ferdeghini, A, Ctardi, M, Koz&kov&, 
M, Taddoi, M. Tuonl, A, Blonde, CNR Inslttute of Clinical Physiology P/n: 
Institute of Clinical Medicine, University of PiN, Italy 
Background: in hypemhote~tomlemla, animpairment of endothelium-depen. 
dent vasodllatlon has boon demonstrated oven in arteries free from atlteto. 
sclomtio atonosia, Whether or not high plasma cholesterol (CH) per ae may 
lend to endothelial damape i~ still debated, 
Aim of the Study: to Investigate the relations between CH, leukecyle 
adhesiveness and poflphomt mlcroclmulsloq/blood flow in a clinical model 
el hyparcholeotemlemta undergoing sharp CH venations, 
Methods: In 8 patients with familial hypercho!astemlemia (FH) under- 
going LDL.aphomaia treatment, serum lipide, plaoma intercellular adhesion 
molec~llo (slCAM1), endefhetium leukocyte adhesion molecule (sELAM1), 
tnftammafton and ooagulation indexes were determined I~tom, soon after 
and 2 end 6 days allot aphamsia, At the some time, skin blood flow at 
s lower oKtmmity was measured by Laser Doppler bafom and after I(~¢e~ 
thermio stimulation at 44 ~, 
Restllt~: LDL-aphero=~is reduced CH, CH.LDL, ape B, TG and Lp(a) 
by 74%, 82%, 79%, 66%, 86%, respectively, slCAMt and sELAMt betoce 
aphemsts whore higher than in healthy controls, and decmssed after .but 
not by. aphoresls (p • 0,0011, Individual sICAMt and sELAMt 10elgin and 
after aphemsis whom poslkvoty cormlatnd with CH(p -~ 0.001 and < 0.02). 
Resting and stimulated skin blood flow in FH was slgeilceantly lower than 
in normal controls before, and refumed to normal alter epheresis. All van+ 
ables were still Improved after 2 days. The rebound curves of CH, adhesion 
molecules and microclm~h~toW blood flow were positively co~elate<l each 
other. No changes in inflammation and coagulation factors were found. 
Conclusion: in FH, acute end massive CH Iowenng is paralleled by down- 
regulation of endothelial adhssivanese and msto,ng of normal penpheml 
microclmulatory function, supporting the hypothesis of a direct, reversible. 
endothelial dysfunction due to high plasma CH. 
11:15 
[80"~ Oxid ized Low Density L lpoprote ln  Enhances 
Anoxia-Reoxygenet lon-mediated Apoptosis  in 
Cultured Human Coronary  Artery Endothelial Cells 
D. Li, B. Yang, J.L. Mehta. University of Florida and the VA Medtcal Center. 
Gainesvilte, Fiends, USA 
Low density lipopmteins (ox-LDL) am atherogenic and high levels el ox-LDL 
am associated with la~e infarcts following coronary aries/occlusion and 
mpedusion. Other studies show that cardiomyocyles tmdergo apoptosis 
upon ischemia-mperfusion, perhaps a result el free radical mtease. We 
have recently found that anoxia-moxygenation results in about 20-30% 
apoptosis in cultured human coronary artery endothelial cells (HCAECs), 
and the magnitude ot apoptosis is increased by coincubation o1 HCAECs 
with TNF~. To determine if ox-LDL increases injury to HCAECs during 
anoxia (24 hm)-moxygenation (3 hm), HCAECs were incubated with na- 
tive or ox.LDL and TNF¢~r. Cellular injury was quantitated by measunng LDH 
release. TUNEL, DNA ladder and electron microscopy were used to deter. 
mine changes characteristic o! apoptosis. Presence o1 ox-LDL (20 14oJml) 
inc=eased number of apoptotic cells (40.1 ± 8.8 vs 27.1 + 3.1% tn cells 
exposed to anoxia-reoxygenation alone, P .  0.01). TNF~ (20 ng/mt) further 
increased the effect of ox-LDL (number o1 apoptotic ells 61.8 ± 144 vs 40.1 
8.8. P < 0.01). Low concentrations o1 ox-LDL (1-5 l,g/ml) and native-LDL 
(20 .t~g/ml) under identical conditions did not increase apoptosis. Treatment 
of cells with ox-LDL (20 l~gtml) or ox-LDL (20 .gfml) + TNF=~ (20 ng/ml) 
markedly decreased supemxide dismutase activity (3.67 ± 0.46 and 3.59 
0.64 vs 4.55 ~ 0.17 units/ml in anoxia-moxygenation alone, P ± 0.01) 
and increased the release of LDH. These data indicate thai the toxicity of 
ox-LDL in cultured HCAECs in vitro involves apoptosis. Cx-LDL also aug- 
ments injury to cultured HCAECs during anoxra-reoxygenation, perhaps by 
decreasing endogenous antioxidant activity. 
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1 806-5~ Reversal  of Impaired Endothel ium-dependent 
Vasodilatation In Apollpoprotein E-deficient Mice by 
Recombinant  Apol lpoprote in A'lM,ano 
B.D. Coin, P.K. Shah, J. Yano, M.D. Molloy, S. Cemek, S. Kdul. 
Cedars-Sinai Medical Center, Los Angeles, CA, USA 
We used an atherogenic ApoE-deficient mouse (ApoE KO) model to deter- 
JACC Fcbm;l~' IqgS 
AIi~TR,M'T.% Or;d 61A 
mine whether treatment with recombinant (ApoM) would restore the imp.qire~ 
endotholium-dependent vasedilatatton in these mice, Untreated ApoE KO 
mica, fed a high-¢holesferel diet, were secnfced at 25 (ApsE25, n ,~ 5) or 
30 weeks (ApoE30, n = 6). Treated mica rocatved 20 (ApoM 20, n =~ 9) or 
80 mg/k~"dose (ApoM 80, n = 10) of ApoM complexed with 1he phespholipid 
earner DPPC, or DPPC alone (n .  3) intravenously on alternate days from 
25 tO 30 weeks. C57BL/6J m*ce (25- and 30-wk old. both n =. 5) were used 
an wdd,lype (WT) CO~t'tOI, Vascular r t~pen~ tO acelyloholine lAth, I uM) 
were examined in pmssunzed aOflas (t.5 • 0,1 ram; 80 mmHg) perfused in 
VlffO, Changt~ in dlamator wete llm~a~ur1~l, and msdansea were oxpros.ed 
as % change in d~ametef (maan :t SEMI of pmconstncled adenes 
WT t~5 wkt WT (30 ~k) ApoE~25 .~OEaCl ApoM (20) APoM IR0) 0PPC 
'p - 00.5 vs W~ 'p,  O00t vs ~ tp.  0 01 vs ~ooE 30 wk ANOVA 
Conc~s~: These d~!ta ~t rate  the! in lhia genetic model of athero. 
sclerosis, treatment wzlh recomi~nant ApoM markedly attenuates Impairment 
Of endothet iu~ndent  vaso(1*tat~ responses 
11:45 
Pot~mtlate the Mnogeni¢ Effect of 
Serotonin on Va~'ular Smooth Mu=cle Cell= 
S Koba. R Pakala. T Katagm, C.R ~ .  tJ~v ot Telas. Houslt~n. TX, 
USA 
Background. Pre~mus stud.s have Shown that ~ low ~ .  =so den- 
stty and low densfly hp~arotems (~'LDL IDIL and LDL) from hypedipiden~c 
I~asma am more alhemge~c titan those from normal plasma. Since platelet 
aggregahon at s;tes of atherosderotm mlun/exposes the cells to high con- 
centrahons ol serotonm (SliT), a known mttogen for vascular sm~olh ff==~l~ 
cells (VSMCI, we ezammed whether VLDL IDL of LDL from plasma of 1% 
cho~)'terof-fed ~ can po~enhate the mlfogen~c effect of 5HT on VSMC 
AfethoctS: Growth arrested primary rabl~ VSMC were ir~.-'ubated wdh 
d~fferenf concentrabons of V1.DI. IDL or LDL m the presence or absence of 
petluss~ tozm IPTXI (t0 ng/mL) for 24 hrs followed by l @  w~h 5HT 
for 24 his. 3H- t~ne incoq:x~abon emo DNA was then measured 
* ! 
; E.~ -: .... ; ..L 
f [: ~,~I.+! 
! ~:!i!Itl i i  
Results: There was a synergistic mter&~on between ~-tipoprofeins and 
5HT on VSMC proliferation. PTX reversed the mitogenic effect of SPIT. bul 
not that of t¢-Iipoproteins. 
Conclusion: These results suggest that even tow concentration of #-Iipo- 
proteins from hypercholesterolemic plasma may significantly potentiate the 
mitogente effect of 5HT released by aggregating plalelels at sites of vascular 
damage. 
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J-80--~ Initial Follow-up Report of 1Yanscathetsr Maze 
Procedure for Treating Patients With Atrial 
Fibrillation 
C, Pappone, S. Shpun, F. Lambert(, G. Vicedomini, ML  Loricchio, 
S L. Chiemhia, S, BemHaim. IRCCS H San Raffae/e, Milano. Italy 
Transcatheter "Maze" procedure was performed in patients with paroxysmal 
atrial fibrillation, using the CARTO ° non.fluorosco~¢ nawgaf~on system 
Mefhoc/s 15 I~bents (11 M/4 F mean 46 I y~ars) undo..wenl reaping of 
both atna dunng pacing from the ~fAI coronary sinus The left afnum wa~ 
accassed through a Iranseptal approa(n Ra~tmq~mnc'y (RF) catheter ~:p 
lation (4 mm tip, NAVI-STAR) were a l~ following the n~4atl:.ng l)rooedum 
In the left atnum the abtat~on line er, circh~d the supe~ putmonary ve~s an  
wan connected fo the Mltml ann~us, while three lines (mt.~caval; Isthmal; 
ant~ro-sePtal) were deptoy~d in the ngh| alfPJm, Pallen~ had ~1 ~ of 9.2 
y~ara of afna! fibnllafC¢l with a mean of 4 ep~zcle~ per week, fo¢ an averl~ge 
duration Ol 16 hours ( ra~ 2.-24), 
Results; The rn~a~ lengt11 of the left sins| lesk-~a was 21 (1 :z 53 ram, with 
65 ~- 17 RF pulses, In the fight mnum ~ k~gth O! the lines ~ t@t 
66 mm with 34 -~ ? RF pullms, Atnat eleclncal transport was restored ~n ati 
dafmflls. After a mean follow.up Of t6 weeks Irange 5.-26), ~unua dW'Rm~ was 
restored in 11 patmnls. Two other datienls are in sinus d ly~ tJ~r~ ~lgs, 
while two are still in afnal fibnllst~n, but with a much less frequency and 
duratcm Of episodes. 
Conclus~m The lranscatheter mass procedure ts mproduclbk~ ar~l safe 
wsfh acceptable radial success rate. 
10:45 
~ Oeflbri!!atlon Guided Mapping and Radlofmquenoy 
Ablation of Focal Alhrlel Rbdllatlon 
C..P Lau. H .F T~IE~t G.M. Ayem t . Unn~nm'y of Hong Kong, Queen Mary 
Hosptal, Hong Kong, China: 'tnComml, Redmond, USA 
Recem sludies demonstrated that sinai hbngahon IAFl may have a focal 
origin clue fo a s=ng~ rapK~ discharging focus, allllOugh reliable n~ng 
tS dePeflOent on the presence ot fn~que~ se l t - ten~ funs of AF or an 
,n~iatmg atrial so'topos, and cannot be applied in ~ who devekat:~ AF 
dunng the procedure We hypothesize that ~ u s  sinai d~fibnllalmn 
[TADF] can be used as a Iool Io map the mtl]almg locus m mcurmnl A F 
A4~#o../s. TADF were pedom~e0 by u~ng 2 decapofar calP, eter 
m nght atrium [RA] and coronary sinus ICS] in 12 ~ ~pls] w~h c~mn¢ 
AF [CAF] and 10 pts with pam~ AF [PAI:] untreated w~h armam~yrrmc 
drugs. S*multanoousfy I~polar elecfrograms warn recorded from RA (anlem- 
lateral wall and septum), CS and H~ regcm. Left alnel (I.A) mai~ng v~a 
I raq i  pu~dure was a.~so pedormecl m p~ w~th recuwem AF Tempe~- 
ture guided RF ablabon was applied to AF foot w~th earhest areal ~'t~allOn 
dunng that re~nrbated AF. 
Resu/ts: Recurrent AF after lAMP was oosew~d m ~ ~ (23%.) (2 CAF & 
4PAF: 5M. 1 F) wflfr a mean age of 33 ± 4yrs. Norm of them have stmclural 
heart d~sease. Cons=stem eadmsl atrial e ~ m s  w~h various co~ing 
intervals chJnng onset of AF were recorded m m~d CS (n = 2) or dmtal CS (n = 
3) LA ma,opmg showed eadiest atnal elecfrograms w~th cemr~Jgal ac~ation 
paffem at nght superior pulmonary vein [PV] (n = 2), left superior PV (n = 2) or 
left mfenor PV (n = 1) RF energy (mean RF pulses: 14 : 8) was delivered fo 
these s~tes wdh compete and papal successful elimination of AF recurrence 
.'n 3 and 2 p~s reap. Transient fermmafmn or AF was observed in 2 pts dunng 
RF ablahon During a mean fotk:~.up of 3 months, 3 pls had no AF recurrent 
and I pf had significan= ~nprovemenl 
Conc/uszo,'~ 1} A sul~aroup of young AF pts have 8 focal source of AF 
that appears ro be responible for eady retnthation of AF 2) TADF guided 
map~ng and RF ablahon =s a uselul method for curatwe therapy on DiS w~th 
focal AF 
11:00 
~0"~ Simplif ied Strategy for Atdal Rut tsr  Ablat ion Using a 
Single Electrode Catheter for Detection of  
Functional  B lock Within the Pos~dor  Isthmus 
S Willems, C Weiss. M. Hoffmann. T. Meinertz Unn~ersffy Hos~tal 
E~pendort Hamburg. Germany 
Background: Catheter ablation onentafed on the ~nductron of a run.renal 
mtraatnal btock wffhin the postenor Lsthmus (PI) of the_ tncus~d annulus has 
bee. shown to effectively abolish atn~l flutter (Aflut). In orcler to ,'nprevo and 
s~mplify the current technique we explored a novel sfratecJy based on nght 
atnal (RA) and coronary sinus (CS) mapping u~ng a single transfemoral 
etectroo~ catheter 
Methods: A 7-F catheter (Medtron~JCardierhythm. USA) composed of 
two segments with 20 electrodes was used for RA and CS stimulation and 
actwation mapping lncludmg the PI. Multiple steenng mechanisms allowing 
intubation and posiboning of the d~'tal part wdhin the CS were incorporated 
into the electrode catheter. 
Resuffs: 20 pts. referred for radiofrequency current (RFC) ablation of com- 
mon type Aflut. were included. Adequat posd~oning of the mapping catheter 
was achieved via a ,,'-;ansfemoral pproach in all pts. after 8 2 ~ 4.2 mm 
providing stable electrogram recordinq5 dunng the procedure The single 
catheter mapping technique detecle0 sig='.ificant RFC-mduCed (median: 17. 
